Top news from HRS: Bluetooth pacemakers, ICD implantation and more
Click Here to Manage Email Alerts
Healio and Cardiology Today have compiled a list of the top news from the virtual Heart Rhythm Society Annual Scientific Sessions. Readers were most interested in radiation treatment for ventricular tachycardia, subcutaneous vs. transvenous ICDs, pacemakers with Bluetooth capabilities and more.
Single radiation treatment may reduce ventricular tachycardia burden
A single noninvasive radiation therapy treatment safely reduced the burden of ventricular tachycardia, with effects persisting for 2 years in most patients, according to data from the ENCORE-VT trial presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
PINNACLE FLX: Next-generation LAA closure device safe, effective
A next-generation device for closure of the left atrial appendage to prevent thrombus embolization in patients with nonvalvular atrial fibrillation met its safety and efficacy goals, according to the results of the PINNACLE FLX study. Read more
New brain infarcts present at 2 years in more than 5% of patients with AF despite anticoagulation
In well-treated patients with atrial fibrillation, most of whom were on oral anticoagulation, more than 5% had a new brain infarct at 2 years, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Subcutaneous ICD noninferior to transvenous ICD for primary, secondary prevention
A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ICD-related adverse events in patients indicated for such treatment, according to data from the PRAETORIAN trial presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Atrial fibrosis predicts poor outcomes in embolic stroke of undetermined source
In patients with embolic stroke of undetermined source, atrial fibrosis predicted recurrent stroke or new atrial fibrillation, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Leadless pacemaker confers similar complications, survival at 30 days as transvenous device
Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Contact force-sensing catheter safe, effective for persistent AF
Ablation with a porous tip contact force-sensing catheter was safe and effective in patients with persistent atrial fibrillation, according to data from the PRECEPT study presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
UNTOUCHED: Subcutaneous ICD meets performance goal for inappropriate shock
A subcutaneous implantable cardioverter defibrillator had a high rate of freedom from inappropriate shock at 18 months, exceeding a performance goal, according to the primary results of the UNTOUCHED study. Read more
Pacemakers with Bluetooth capabilities confer improved transmission success rates
Pacemakers that were compatible with technology for remote monitoring with a smartphone or tablet had a higher rate of scheduled transmission success compared with other remote monitoring options that required a wand or wireless automatic communication to a bedside console, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Personalized risk assessment may predict ICD benefit
The risk for ventricular tachyarrhythmic events weighted against the risk for nonarrhythmic mortality predicted the likely benefit of implantable cardioverter defibrillators, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions. Read more
Collapse
Click Here to Manage Email Alerts